May 21, 2018 4:10 AM ET

Biotechnology

Company Overview of MaxCyte, Inc.

Key Executives for MaxCyte, Inc.

NameBoard RelationshipsTitleAge
Douglas Arthur Doerfler 119 RelationshipsCo-Founder, Chief Executive Officer, President and Director61
Ronald Evan Holtz CPA7 RelationshipsCompany Secretary, CFO & Executive Director59
Debra K. Bowes M.TNo RelationshipsExecutive Vice President of Business & Strategic Development--
Brad Calvin No RelationshipsExecutive Vice President of Global Commercial Operations--
Claudio Dansky Ullmann No RelationshipsChief Medical Officer--

MaxCyte, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
J. Stark Thompson Ph.D. 7 RelationshipsMaxCyte, Inc.75
Douglas Arthur Doerfler 119 RelationshipsMaxCyte, Inc.61
Ronald Evan Holtz CPA 7 RelationshipsMaxCyte, Inc.59
William W. Brooke J.D. 28 RelationshipsWallace, Jordan, Ratcliff & Brandt60
Arthur Michael Mandell 24 RelationshipsPrestwick Pharmaceuticals, Inc.64
View All Board Members

MaxCyte, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee J.D.William W. Brooke28 Relationships2 Executives
Compensation Committee Ph.D.J. Stark Thompson7 Relationships3 Executives
Nominating Committee Arthur Michael Mandell24 Relationships3 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary$399.7K
399.7K
455.5K
Bonus$184.3K
184.3K
284.9K
Total Short Term Compensation$584.0K
584.0K
391.7K
Total Value of Options
17.5M
Compensation as of Fiscal Year
MaxCyte, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Seattle Genetics, Inc. Announces Resignation of Jonathan Drachman as Chief Medical Officer, Effective May 21, 2018
May 18, 2018 9:16 PM ET
Gilead Sciences Names Harish Manwani to Board of Directors
May 18, 2018 11:33 AM ET
Apexigen Inc. Appoints Frances Rena Bahjat as Vice President, Discovery Research
May 18, 2018 11:00 AM ET
Invitae Corporation Approves Election of Randal W. Scott as Class II Director
May 18, 2018 10:07 AM ET
Insmed Incorporated Appoints Leo Lee to Its Board of Directors
May 17, 2018 8:11 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact MaxCyte, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.